Longeveron Inc. (NASDAQ:LGVN) Director Purchases $75,000.25 in Stock

Longeveron Inc. (NASDAQ:LGVN) Director Rock Soffer acquired 31,915 shares of the stock in a transaction on Thursday, April 11th. The shares were acquired at an average price of $2.35 per share, with a total value of $75,000.25. Following the purchase, the director now owns 208,534 shares in the company, valued at $490,054.90. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Longeveron Stock Performance

NASDAQ:LGVN traded down $0.33 during trading hours on Friday, reaching $1.69. 494,120 shares of the stock were exchanged, compared to its average volume of 820,154. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.21. The firm has a 50 day simple moving average of $4.32 and a 200-day simple moving average of $12.41. Longeveron Inc. has a 52 week low of $1.62 and a 52 week high of $44.00. The stock has a market capitalization of $4.24 million, a P/E ratio of -0.17 and a beta of 0.21.

Longeveron (NASDAQ:LGVN) last released its earnings results on Tuesday, February 27th. The company reported ($2.50) EPS for the quarter, missing analysts’ consensus estimates of ($2.10) by ($0.40). Longeveron had a negative return on equity of 209.14% and a negative net margin of 3,020.17%. The firm had revenue of $0.06 million for the quarter, compared to the consensus estimate of $0.21 million. As a group, sell-side analysts forecast that Longeveron Inc. will post -8.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Citadel Advisors LLC bought a new stake in shares of Longeveron in the 4th quarter worth approximately $44,000. Northern Trust Corp acquired a new stake in Longeveron in the 2nd quarter valued at approximately $63,000. State Street Corp acquired a new stake in Longeveron in the 2nd quarter valued at approximately $88,000. Geode Capital Management LLC increased its position in Longeveron by 78.6% in the 2nd quarter. Geode Capital Management LLC now owns 66,392 shares of the company’s stock valued at $224,000 after acquiring an additional 29,212 shares during the period. Finally, Boothbay Fund Management LLC acquired a new stake in Longeveron in the 2nd quarter valued at approximately $254,000. Institutional investors own 10.01% of the company’s stock.

About Longeveron

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors.